Wistar Scientists Discover Fructose Fuels Cancer Spread, Unexpected Link

Scientists at the Wistar Institute, a renowned biomedical research center in Philadelphia, have made an unexpected discovery that could rewrite the rules of cancer metabolism: fructose, the simple sugar widely used in processed foods and sweetened beverages, appears to be a direct driver of cancer spread. In a study published this week in the journal Cell Metabolism, the team shows for the first time that fructose does not merely serve as a fuel for cancer cells but actively remodels their membranes to make them more invasive. The findings challenge decades of research that focused almost exclusively on glucose and suggest that dietary fructose may play a far more important role in metastasis than previously assumed. The study, led by Dr. Matteo C. Rossi, a senior investigator at Wistar's Cancer Metabolism Program, was conducted across multiple cancer types, including colorectal, breast, and pancreatic cancers, and involved both cell cultures and mouse models.

A Surprise in the Metabolic Pathway

The research began with a simple question: why do some cancer cells readily metastasize even when glucose levels are tightly controlled? For years, the prevailing view in oncology was that cancer cells have a voracious appetite for glucose, the primary sugar used by the body for energy, and that this 'sweet tooth' underpins tumor growth and spread. Fructose, on the other hand, was largely regarded as a harmless bystander, merely a sweetener that the liver processes and converts to fat. The Wistar team, however, observed something unexpected when they grew cancer cells in a medium where fructose was the only sugar available. Instead of remaining quiet, the cells became more elongated, more mobile, and far more aggressive in their ability to invade surrounding collagen tissue.

'We were genuinely surprised,' said Dr. Rossi in a press briefing. 'We expected fructose to be metabolically inert or even inhibit growth, because it does not directly enter the glycolytic pathway in the same way glucose does. But the cells loved it, and they used it to become more invasive.' The researchers traced this behavior to a two-step metabolic process. First, fructose enters the cell via the GLUT5 transporter, a protein expressed on the surface of certain cancer cells. Then, an enzyme called ketohexokinase, or KHK, converts fructose into fructose-1-phosphate, which in turn stimulates the production of lipids, particularly phospholipids. These lipids are incorporated into the cell membrane, increasing its fluidity and flexibility, physical properties that allow cancer cells to squeeze through tiny gaps in tissues and enter the bloodstream.

How Fructose Drives Metastasis

To confirm that this mechanism was not a tissue-culture artifact, the team turned to animal models. They implanted human cancer cells into mice and then placed the mice on a diet in which a portion of their carbohydrate calories came from fructose, equivalent to about 50 grams per day for an average human, a level common in a Western diet. After eight weeks, the mice on the high-fructose diet had significantly more metastatic nodules in their lungs and livers than control mice fed a glucose-based diet or a regular chow diet. In one breast cancer model, the increase in lung metastases was more than twofold. Similar results were seen in colorectal and pancreatic cancer models, suggesting that the effect is not limited to a single tumor type.

'This is not about sugar feeding the tumor in the way we normally think,' said Dr. Jessica L. Warren, a postdoctoral fellow and first author of the paper. 'Glucose is primarily used for energy, but fructose is being used as a building block for the cell membrane, essentially a raw material for a more flexible and invasive surface.' The team used advanced imaging techniques, including confocal microscopy and lipid mass spectrometry, to show that cancer cells incubated in fructose-enriched media had a higher ratio of unsaturated phospholipids, which makes membranes less rigid. Electron microscopy revealed that these cells produced more finger-like protrusions called invadopodia, which cancer cells use to chew through the extracellular matrix.

Beyond Glucose: Rethinking Sugar and Cancer

For clinicians and nutritionists, the finding adds a new layer of complexity to the ongoing debate over sugar and cancer. While it has long been known that obese patients and those with type 2 diabetes face elevated cancer risk, the connection between specific sugars and metastasis has remained murky. Most studies have focused on glucose, partly because cancer cells are notoriously dependent on it for ATP production. Fructose, however, is everywhere in the modern food supply, from high-fructose corn syrup in soft drinks and processed snacks to so-called 'natural' sweeteners like agave nectar. The Wistar team notes that while fruits contain fructose, they also contain fiber, vitamins, and polyphenols that may mitigate its effects, and the absolute amount of fructose in a piece of fruit is far lower than in a sugary soda.

'This doesn't mean people with cancer should never eat fruit,' said Dr. Alan T. Meyers, a medical oncologist at Thomas Jefferson University who was not involved in the study. 'But it does mean we need to be much more careful about advising patients to simply 'eat whatever they want' during treatment. If a high-fructose diet can accelerate metastasis, that has profound implications for dietary guidelines.' Dr. Meyers, who often treats patients undergoing chemotherapy, said he would now ask his patients about their intake of sweetened beverages and processed foods. He also cautioned, however, that the findings are from mice and cell cultures, and it remains to be seen whether the effect holds in humans, whose metabolism and gut microbiome differ significantly.

Expert Reactions and Cautions

Several independent cancer researchers praised the study for its mechanistic detail but urged caution before drawing clinical conclusions. Dr. Yuki Tanaka, a metabolic biologist at the University of California, San Francisco, called the work 'elegant and convincing at the preclinical level.' She pointed out that the mice were fed fructose as a purified molecule, whereas humans consume fructose alongside glucose, protein, and fat, which could alter absorption and metabolism. 'The challenge is dissecting the relative contribution of fructose versus overall caloric excess,' she said. 'We know that obesity itself is a risk factor for cancer progression, and high-fructose diets often lead to weight gain and insulin resistance.'

Tanaka also noted that the enzyme KHK is primarily found in the liver, kidney, and intestine, but the Wistar team found it in certain cancer cells. 'That is the surprising and possibly important part, that some tumors express KHK and can directly metabolize fructose,' she said. 'If that is validated, then inhibiting KHK might block metastasis without affecting normal tissues.' Indeed, the Wistar team has already begun experiments with a small-molecule KHK inhibitor, currently in clinical trials for nonalcoholic fatty liver disease, in their mouse tumor models. In preliminary data, the inhibitor reduced fructose-driven metastasis by more than 80 percent, without causing obvious toxicity. 'We are cautiously optimistic,' said Dr. Rossi. 'We are not suggesting that this drug be repurposed for cancer today, but it demonstrates that the pathway is druggable.'

Clinical Implications and What's Next

The study's conclusions, if confirmed in human studies, could have multiple practical implications. For one, it may help explain the well-known but poorly understood association between Western dietary patterns and increased cancer mortality. It could also lead to a new class of tests that measure fructose-metabolism gene expression in tumor biopsies, helping oncologists tailor dietary and pharmacological advice. In the near term, Dr. Rossi's team plans to analyze existing tissue banks from cancer patients to see whether high expression of GLUT5 or KHK correlates with worse outcomes. They also intend to launch an observational trial in which patients with early-stage cancer will be asked to record their dietary intake and wear continuous glucose and fructose monitors, though validated fructose sensors for wearable devices are still under development.

The Wistar team is not alone in this pursuit. A 2021 study from researchers at the University of Tokyo found that dietary fructose promoted the growth of colorectal cancer in mice, though it did not examine metastasis directly. A 2023 paper from Memorial Sloan Kettering Cancer Center showed that fructose can be a fuel source for certain pancreatic cancer cells through an alternative pathway. The new Wistar work differs, however, because it identifies a specific structural role for fructose and demonstrates a mechanism for invasion. The scientific community is therefore treating the finding with sober interest, and the peer-review process for the Cell Metabolism paper was unusually rigorous, according to the editor, who noted the reviewers were evenly split in initial assessments but ultimately unanimous in appreciating the depth of the evidence.

Broader Public Health Context

Outside the laboratory, the study adds a new dimension to decades of public health messages about sugar. Global per-capita fructose consumption has risen steadily since the 1970s, largely due to the widespread adoption of high-fructose corn syrup in the United States and other industrialized countries. The World Health Organization recommends limiting free sugars, which include both added sugars and the sugars naturally present in honey and fruit juices, to less than 10 percent of total energy intake. The new findings, if translated to humans, suggest that meeting those guidelines could be important not only for preventing obesity and Diabetes but also for reducing the likelihood of cancer progression in patients already diagnosed.

However, researchers stress that this is not a warning against all carbohydrates. 'Glucose is the preferred fuel for the brain and muscles, and our bodies have evolved complex systems to regulate it,' said Dr. Warren. 'Fructose, in the amounts humans consume today, is an evolutionary novelty. Our ancestors mostly got it from seasonal fruits and honey, not from a 12-ounce can of soda. In that sense, this is a mismatch with our metabolic machinery.' She also pointed out that the study has a positive flip side: understanding how fructose makes membranes flexible could reveal a vulnerability. 'If we can block the fatty acid pathway downstream of fructose, we might be able to prevent the cells from becoming invasive in the first place.'

The Wistar Institute, which was founded in 1892 and is recognized as a center for cancer research, plans to make its raw data publicly available and will hold a workshop in Philadelphia next month to discuss the next steps with researchers from other institutions. The team is also in talks with the National Cancer Institute to include dietary fructose questionnaires in a large prospective cohort study on cancer survivors. 'We are at the beginning of a long journey,' said Dr. Rossi. 'But for the first time, we have a clear molecular connection between a specific sugar and the spread of cancer. That gives us a target, and targets are what we need.'